Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study.
Jan Philipp BewersdorfShai ShimonyRory M ShallisYiwen LiuGuillaume BertonEva J SchaeferAmer M ZeidanAaron GoldbergEytan SteinGuido MarcucciRebecca P BystromR Coleman LindsleyEvan C ChenJorge RamosAnthony SteinVinod A PullarkatIbrahim AldossDaniel J DeAngeloDonna S NeubergRichard M StoneSylvain GarciazBrian J BallMaximilian StahlPublished in: American journal of hematology (2024)